Inventor · disambiguated record
Rosella Ombrato
Also filed as: OMBRATO ROSELLA
11 granted patents·1 pending application·6 citations·filing 2007–2019
81Inventor score
Files withACRAF10ALISI MARIA ALESSANDRA1AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO—A C R A F S P A1
Top patents by PatentIndex Score
12 records- 0176US8017644B22-arylindole derivatives as nPGES-1 inhibitorsACRAF·Filed 2007·Granted Sep 13, 2011·3 cites·20 claims
- 0275US9163013B2Use of 1H-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitorsACRAF·Filed 2013·Granted Oct 20, 2015·3 cites·12 claims
- 0357US9611249B21H-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitorsACRAF·Filed 2013·Granted Apr 4, 2017·0 cites·16 claims
- 0454US10640488B2Antibacterial compoundsACRAF·Filed 2017·Granted May 5, 2020·0 cites·17 claims
- 0554US10633366B2Antibacterial compoundsACRAF·Filed 2017·Granted Apr 28, 2020·0 cites·18 claims
- 0654US10160746B21H-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitorsACRAF·Filed 2017·Granted Dec 25, 2018·0 cites·15 claims
- 0750US2017174657A11h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitorsACRAF·Filed 2017·Application pending·0 cites
- 0848US8507528B22-alkyl-indazole compounds for the treatment of certain cns-related disordersALISI MARIA ALESSANDRA·Filed 2007·Granted Aug 13, 2013·0 cites·8 claims
- 0943US11472795B21H-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitorsAZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO—A C R A F S P A·Filed 2019·Granted Oct 18, 2022·0 cites·20 claims
- 1042US9700551B2Use of 1H-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitorsACRAF·Filed 2015·Granted Jul 11, 2017·0 cites·21 claims
- 1132US10369130B2Antibacterial compoundsACRAF·Filed 2015·Granted Aug 6, 2019·0 cites·13 claims
- 1232US10221144B2Antibacterial compounds having broad spectrum of activityACRAF·Filed 2015·Granted Mar 5, 2019·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Rosella Ombrato files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →